<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5">
 <label>5</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reck</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Rodriguez-Abreu</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Robinson</surname>
    <given-names>AG</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Csoszi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Fulop</surname>
    <given-names>A</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Pembrolizumab Versus Chemotherapy for PD-L1-Positive non-Small-Cell Lung Cancer</article-title>. 
  <source>N Engl J Med</source> (
  <year>2016</year>) 
  <volume>375</volume>(
  <issue>19</issue>):
  <page-range>1823â€“33</page-range>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1606774</pub-id>
 </mixed-citation>
</ref>
